BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Motta I, Mancarella M, Marcon A, Vicenzi M, Cappellini MD. Management of age-associated medical complications in patients with β-thalassemia. Expert Review of Hematology 2020;13:85-94. [DOI: 10.1080/17474086.2020.1686354] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Carsote M, Vasiliu C, Trandafir AI, Albu SE, Dumitrascu MC, Popa A, Mehedintu C, Petca RC, Petca A, Sandru F. New Entity-Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement. Diagnostics (Basel) 2022;12:1921. [PMID: 36010271 DOI: 10.3390/diagnostics12081921] [Reference Citation Analysis]
2 Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. The Lancet 2022;399:2310-24. [DOI: 10.1016/s0140-6736(22)00536-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Sayani FA, Lal A, Tasian GE, Mukaddam MA, Killilea DW, Fung EB. Kidney Stones in Transfusion-Dependent Thalassemia: Prevalence and Risk Factors. OJU 2022;12:209-227. [DOI: 10.4236/oju.2022.124021] [Reference Citation Analysis]
4 Daar S, Al Saadoon M, Wali Y, Al Mujaini R, Al Rahbi S, Chan MF, Al-Siyabi A, Alansary N, Mahadevan S, Al-Adawi S. Cognitive Function in Adults with Beta-Thalassemia Major in Oman: A Pilot Study. Oman Med J 2021;36:e322. [PMID: 34868668 DOI: 10.5001/omj.2021.101] [Reference Citation Analysis]
5 Setoodeh S, Khorsand M, Takhshid MA. The effects of iron overload, insulin resistance and oxidative stress on metabolic disorders in patients with β- thalassemia major. J Diabetes Metab Disord 2020;19:767-74. [PMID: 33520802 DOI: 10.1007/s40200-020-00560-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mancuso A. Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia. BMC Gastroenterol 2020;20:409. [PMID: 33297979 DOI: 10.1186/s12876-020-01542-2] [Reference Citation Analysis]
7 Vitrano A, Meloni A, Addario Pollina W, Karimi M, El-Beshlawy A, Hajipour M, Di Marco V, Hussain Ansari S, Filosa A, Ricchi P, Ceci A, Daar S, Titi Singer S, Naserullah ZA, Pepe A, Scondotto S, Dardanoni G, Bonifazi F, Vichinsky E, Maggio A. A complication risk score to evaluate clinical severity of thalassaemia syndromes. Br J Haematol 2021;192:626-33. [PMID: 33216983 DOI: 10.1111/bjh.17203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
8 Safarnezhad Tameshkel F, Karbalaie Niya MH, Zamani F, Motamed N, Ajdarkosh H, Vafaeimanesh J, Khoonsari M, Sohrabi MR, Aten S, Azarkeivan A, Eslami MS, Perumal D, Maadi M, Ghanbari B, Keyvani H. Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study. Arch Virol 2020;165:2193-203. [PMID: 32638116 DOI: 10.1007/s00705-020-04728-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Farmakis D, Giakoumis A, Angastiniotis M, Eleftheriou A. The changing epidemiology of the ageing thalassaemia populations: A position statement of the Thalassaemia International Federation. Eur J Haematol 2020;105:16-23. [PMID: 32198891 DOI: 10.1111/ejh.13410] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
10 Zafar S, Saleem K, Rashid A. An Unusual Presentation of a Patient with Leg Ulcers: A Case Report. Cureus 2019;11:e6293. [PMID: 31938587 DOI: 10.7759/cureus.6293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]